A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients

European Psychiatry

Volumn 21, Issue 8, 2006, Pages 539-543

  San, L ^a   Arranz, B ^a   Querejeta, I ^b   Barrio, S ^c   De la Gandara J ^d   Perez V ^e  

^a HOSPITAL SAN RAFAEL   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c Hospital San Juan de Dios   (Spain)

^d HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Agitation; Atypical antipsychotics; Intramuscular; Olanzapine; Schizophrenia

Indexed keywords

OLANZAPINE;

ADULT; AGED; AGGRESSION; AGITATION; ARTICLE; BIPOLAR DISORDER; BIPOLAR MANIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE DRUG DOSE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGGRESSION; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; TREATMENT OUTCOME;

EID: 33845204518     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2006.03.005     Document Type: Article

References (22)

1. Beaudoin M.N., Hodgins S., and Lavoie F. Homicide, schizophrenia and substance abuse and dependency. Can. J. Psychiatry 38 (1993) 541
2. Breier A., Meeham K., Birkett M., David S., Ferchland I., Sutton V., et al. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch. Gen. Psychiatry 59 (2002) 441-448
3. Citrome L. New treatments for agitation. Psychiatr. Q. 75 3 (2004) 197-213
4. Citrome L., and Volavka J. Psychiatric disorders and violence. In: Tardiff K. (Ed). Medical Management of the Violent Patient. Clinical Assessment and Therapy (1999), Marcel Dekker, Inc, New York 125-152
5. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Health and Welfare. Washington DC 338 (1976) 534-537
6. Humphreys M.S., Johnstone E.C., Mac Millan J.F., and Taylor P.J. Dangerous behavior preceding first admission for schizophrenia. Br. J. Psychiatry 161 (1992) 501
7. Kapur S., Arenovich T., Agid O., Zipursky R., Lindborg S., and Jones B. Evidence of antipsychotic effects within the first 24 hours of treatment. Am. J. Psychiatry 162 (2005) 939-946
8. Kay S.R., and Sevy S. Pyramidical model of schizophrenia. Schizophr. Bull. 16 (1990) 537-545
9. Kunik M.E., Yudofsky S.C., Silver J.M., and Hales R.E. Pharmacologic approach to management of agitation associated with dementia. J. Clin. Psychiatry 55 Suppl (1994) 13-17
10. Meehan K., Zhang F., David S., Tohen M., Janicak P., Small J., et al. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J. Clin. Psychopharmacol. 21 (2001) 389-397
11. NICE. Violence: The short-term management of disturbed/violent behaviour in in-patient psychiatric settings and emergency departments. Clinical Guideline 25 (2005), London NHS
12. Pilowsky L.S., Ring H., Shine P.J., Battersby M., and Lader M. Rapid tranquillisation. A survey of emergency prescribing in a general psychiatric hospital. Br. J. Psychiatry 160 (1992) 831-835
13. San L., Arranz B., and Escobar R. Pharmacological management of acutely agitated schizophrenic patients. Curr. Pharm. Des. 11 19 (2005) 2471-2477
14. Sebastian C.S., Glazer W., and Buckley P.F. Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia. Curr. Med. Chem. 11 3 (2004) 329-342
15. Tulloch K.J., and Zed P.J. Intramuscular olanzapine in the management of acute agitation. Ann. Pharmacother. 38 (2004) 2128-2135
16. Turczynski J., Bidzan L., and Staszewska-Malys E. Olanzapine in the treatment of agitation in hospitalised patients with schizophrenia and schizoaffective and schizofreniphorm disorders. Med. Sci. Monit. 10 5 (2004) PI74-PI80
17. Verdoux H., and Bégaud B. Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions?. Br. J. Psychiatry 185 (2004) 93-94
18. Virkkunen M. Observations on violence in schizophrenia. Acta Psychiatr. Scand. 50 (1974) 145
19. Wagstaff A.J., Easton J., and Scott L.J. Intramuscular olanzapine. A review of its use in the management of acute agitation. CNS Drugs 19 2 (2005) 147-164
20. Wright P., Birkett M., David S.R., Meeham K., Ferchland I., Alaka K., et al. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am. J. Psychiatry 7 (2001) 1149-1151
21. Yildiz A., Sachs G.S., and Turgay A. Pharmacological management of agitation in emergency settings. Emerg. Med. J. 20 (2003) 339-346
22. Yudofsky S.C., Silver J.M., and Hales R.E. Treatment of Agitation and Aggression. In: Schaltzberg A.F., and Nemeroff C.B. (Eds). The American Psychiatric Press Textbook of Psychopharmacology (1998), American Psychiatric Press, Washington DC 881-900